How healthcare practice consolidation strategies that succeed on the contracting side often stall on the revenue cycle side—and what changes when leadership treats specialty variation as something to design around rather than work around.
Multispecialty consolidation has been one of the more consistent storylines in healthcare finance. The AMA’s most recent Physician Practice Benchmark Survey shows the share of physicians working in private practices dropped from 60% in 2012 to 42% in 2024, with private equity, health system roll-ups and the search for negotiating leverage continuing to pull independent practices, ambulatory surgery centers and community clinics under shared corporate roofs. The financial logic of healthcare revenue cycle consolidation is
straightforward: one tax ID, one contracting team, one billing platform and presumably one set of efficiency gains.
The reality on the revenue cycle side is rarely that clean. Groups that migrate every specialty onto a single enterprise platform often watch denial rates climb in the first six to twelve months after go-live, sometimes past the 10 percent threshold that industry benchmarks flag as a danger zone for financial stability—which on a mid-sized multispecialty platform can represent several million dollars a year in stalled or written-off revenue. The platform is usually not the problem. The problem is the assumption underneath it: that multispecialty medical billing is a uniform administrative function that can be standardized the way payroll or procurement can. At the specialty boundary, that assumption tends to collapse.
Why the claim denial spike is delayed
Most consolidation projects look healthy in the first few months. Implementation partners are still on site. Vendor support teams are scrubbing claims, building one-off edits and pushing work through the clearinghouse by hand. Legacy accounts receivable from the prior systems is still converting to cash, which masks the performance of the new platform.
When that scaffolding comes down, the structural issues become visible. Centralized billing teams, which often inherit a wider scope of specialties than they ever supported individually, lean harder on the platform’s native rule engine. The rule engine was built for the average case, not the orthopedic implant claim or the oncology infusion sequence. Backlogs grow, timely filing deadlines start to slip, and the denial curve bends upward right around the point when leadership expects to see efficiency dividends.
Where multispecialty medical billing standardization fails
Three friction points show up repeatedly in post-implementation reviews. The first is coding and modifier logic. Each specialty carries its own CPT and ICD-10 conventions, its own NCCI edits and its own modifier discipline. Modifier 25, for example, behaves very differently in a primary care visit that includes a minor procedure than it does in a dermatology or cardiology context, and several large commercial payers have continued to tighten their position on modifier usage through recent policy updates. A generic platform that applies the same modifier logic across every department will either over-append modifiers and invite audit risk or under-append them and leave revenue on the table.
The second is provider taxonomy and credentialing. When disparate practices roll up under a single corporate entity, the platform often defaults to a multispecialty designation or to the taxonomy of the founding group. Claims for complex neurosurgical or chemotherapy services then go out under what looks to the payer’s adjudication engine like a family practice taxonomy. The mismatch triggers an automatic denial that has nothing to do with the underlying care and everything to do with how the 837 file was assembled.
The third is documentation. A behavioral health note, an ASC operative report and a primary care encounter all support claims, but they support them in different ways. When the EHR forces a single documentation template across service lines, coders either spend extra time reconstructing clinical detail or submit claims that cannot withstand a medical record review. Medicare Advantage plans, in particular, have leaned harder into post-payment record reviews as front-end prior authorization requirements have eased, which means weak documentation now surfaces as a denial weeks or months after the claim was paid.
Claim denial signals leadership should watch
Executives and board members tracking post-deal performance can catch the breakdown before it shows up in cash by watching a short list of indicators. First-pass clean claim rates that fall below the mid-90s are an early warning, especially when the drop is concentrated in one or two specialties. HFMA’s MAP Keys associate strong performance with rates in the high 90s. A rising share of denials tied to provider specialty mismatch or invalid taxonomy points directly at the taxonomy mismatch already described. Coder productivity that looks stable in aggregate but masks a widening gap between specialties suggests the centralized team is leaning on platform defaults rather than specialty knowledge. Days in accounts receivable that creep up in the second and third quarters after go-live, after the legacy cash has cleared, tend to confirm the pattern rather than start it.
Fixing multispecialty billing without scrapping the platform
The instinct after a rough first year is often to rip the platform out and start over. That tends to be expensive and rarely solves the underlying issue, because a new monolithic system will hit the same specialty boundary on its own timeline.
A more durable approach starts with the platform itself: keep the enterprise system as the system of record and layer specialty-specific RCM logic on top of it, either through configurable rules or through integrated overlay tools that can be updated faster than the core platform’s release cycle. From there, reorganize the billing operation into specialty pods. Coders and follow-up staff stay close to one or two clinical disciplines so that fluency in payer policy, modifier behavior and documentation expectations doesn’t get diluted. Contracting, analytics, denial appeals and clearinghouse management can remain centralized, which preserves the scale benefits that justified consolidation in the first place. The last piece is a real feedback loop from denials back into coding and documentation — when a specific denial reason appears repeatedly in one service line, the fix belongs upstream in the workflow, not in a manual rework queue.
The bottom line
Consolidation works on the contracting side because payers respond to scale. It struggles on the revenue cycle side when administrative technology is asked to erase clinical differences that don’t actually go away. The organizations that get the most out of their platforms are the ones that treat specialty variation as a permanent feature of the operation and design the workflow, the team and the technology layer around it.
This article is for informational purposes only and is not intended as legal, financial, coding or compliance advice.
Practices should consult qualified advisors and internal compliance resources regarding payer requirements,
documentation standards, billing rules and regulatory obligations.
Kristina Colligan
Kristina Colligan is a strategic healthcare leader at Coronis Health with deep clinical and operational expertise. A former provider and practice owner/operator, she brings firsthand insight into scaling physician practices. Kristina drives alignment across care delivery and operations to support execution, patient experience and long-term sustainability.
Coronis Health is a healthcare revenue cycle management partner supporting independent physician practices and health systems. The company provides specialty-focused billing operations, coding expertise, denial management and revenue cycle reporting designed to improve visibility and support decision-making.
